Search

everythinglearnresearchcommunity

for

Search:↓

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Some medicinal plants can help heal wounds and may lead to new treatments.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Thymosin β4 helps improve skin healing and reduce scarring.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

The new delivery method for dutasteride is more effective and has fewer side effects.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

A reliable method was created to measure dutasteride and related molecules in capsules.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Diabetic wounds heal slower than healthy wounds.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.